Recent research describing a role for cells expressing the CD74 cell surface marker in the inhibition of liver fibrosis and spontaneous lung injury in mouse models11, 12 suggested to researchers led by Derrick C. Wan (Stanford University School of Medicine, Stanford, CA, USA) that CD74‐expressing adipose‐derived MSCs may possess enhanced antifibrotic and proregenerative capabilities. Here, CD74 is linked to Hepatic fibrosis.